Tout ce qu’il faut savoir sur les pesticides
There are also some key figures for end usages + some interesting specific links I invite you to read.
maud
DATE : 2016-03-17
Solvay Specialty Polymers, a leading global supplier of high-performance polymers, announced today that Zeniva polyetheretherketone, one of the four products comprising its family of Solviva Biomaterials offered for use in implantable devices, has successfully passed the biocompatibility testing at the China Food and Drug Administration's Tianjin Medical Device Quality Supervision and Inspection Center.
'Obtaining this important biocompatibility testing report facilitates the strategic implementation and launching of Solviva Biomaterials in the China market place,' said Kendra Shoulders, Director of Global Regulatory Affairs for Healthcare, Solvay Specialty Polymers. 'This essential recognition will help local medical OEMs to gain regulatory approval from the China Food and Drug Administration for their implantable devices.'
The inspection center at Tianjin is recognized as the most influential testing agency in the field of orthopedics in China. The test took over a year to complete and during this lengthy process, properties of Zeniva PEEK such as sensitization, intracutaneous toxicity, acute systemic toxicity, sub-chronic toxicity, genotoxicity and bone implant compatibility tests were rigorously examined to ensure biological safety in the human body, an absolute priority for implantable medical devices.
'Solvay's experience as a key materials supplier to the healthcare industry spans more than 25 years. With our broad product portfolio we are firmly positioned as a strategic supplier to the Chinese healthcare industry,' added Dr. Luke Du, Managing Director Asia, and Executive Vice President Solvay Specialty Polymers. 'Obtaining this local and important biocompatibility testing report for Zeniva PEEK signals our further commitment to both national and multi-national medical OEMs.'
Zeniva PEEK boasts a modulus very close to that of cortical bone plus excellent fatigue resistance and toughness. It is offered for use in implantable medical devices for spine, orthopedics, cardiovascular and dental applications. In addition, ZenivaPEEK offers numerous advantages over metals, such as reduction of stress shielding, no heavy metal allergy or ion erosion, and has radiolucent properties which allow x-ray and CT scanning procedures without interference.
Solvay's family of Solviva Biomaterials has been commercially available in China since 2013. In addition to Zeniva PEEK, the product line features Veriva polyphenylsulfone (PPSU), which combines unsurpassed toughness with transparency and excellent biocompatibility and Eviva polysulfone (PSU), a transparent, biocompatible polymer that offers high strength and toughness.
Solviva Biomaterials can be sterilized using all conventional methods including gamma radiation, ethylene oxide, and steam. These sterilizable products are available in grades for injection molding or extrusion, as well as stock shapes for machined components.
The entire range of thermoplastic Solviva Biomaterials is manufactured in an ISO 13485 registered facility and under the relevant aspects of current Good Manufacturing Practices. Solvay's biomaterial manufacturing processes are carefully validated, and enhanced controls provide product traceability. In addition, all materials are tested in an ISO 17025 accredited lab.
Source ENP Newswire
DATE : 2016-03-15
New Teaming Agreement Signed to Grow Business Opportunities
Five thousand homes and businesses in Herten, Germany, will soon benefit from a clean, renewable energy source as Lockheed Martin and Concord Blue begin phase two of a new power generation facility that will transform waste into energy.
Under phase two, Concord Blue has awarded Lockheed Martin Energy a $43 million contract to proceed with all engineering, procurement and construction of the 5 megawatt plant with a planned completion date in 2017.
In 2014, the two companies announced plans to build the facility and have since successfully completed all planning, simulation, supplier logistics and preliminary design, clearing the way for the build to begin.
"The Herten bioenergy facility will provide real benefits to the local area while demonstrating the promising capabilities and international potential of our bioenergy technologies," said Mo Vargas, director of Bioenergy at Lockheed Martin Energy. "We are proud to partner with Concord Blue to help change the way our world addresses the growing challenges of clean energy and waste management."
The bioenergy facility transforms forestry waste to power using Concord Blue's Reformer® technology, which converts waste to energy through a process called advanced gasification. The technology can convert nearly any kind of organic waste into clean, sustainable energy. Unlike other available processes that use hazardous incineration methods, Concord Blue's patented solution converts waste material using heat transfer, which results in no harmful byproducts.
The facility's 5 megawatts of energy output is enough to power about 5,000 homes and businesses. To create its power, the plant will process 50,000 tons of raw waste per year, significantly reducing the need for landfill use.
"The construction of the Herten Project marks an important milestone for our partnership with Lockheed Martin. We continue to be extremely pleased with the quality of work and value they provide to this project and will provide for many projects to come," said Charlie Thannhaeuser, Chairman and CEO of Concord Blue.
Teaming Agreement Extended
Additionally, Lockheed Martin and Concord Blue signed a modification to the existing teaming agreement established in 2013 to extend the partnership ten years though 2026, with options for further extension.
The agreement enables Lockheed Martin to serve as Concord Blue's Engineering, Procurement and Construction (EPC) contractor for future bioenergy conversion projects and to continue serving as the exclusive manufacturing provider of the Concord Blue Reformer.
Concord Blue's unique technology benefits the environment, fulfilling all international, Environmental Protection Agency and European regulations for renewable energy and air emissions. Concord Blue operates globally, with offices in the United States, Germany and India.
Lockheed Martin Energy is a line of business within Lockheed Martin that delivers comprehensive solutions across the energy industry to include demand response solutions, energy efficiency, energy storage, nuclear systems, ocean energy technologies and bioenergy generation.
"Our bioenergy technology is a key element of our portfolio and has the potential to be a true game-changer for both the energy generation and waste management markets," said Frank Armijo, vice president of Lockheed Martin Energy.
Source Stockwatch
DATE : 2016-03-15
Lockheed Martin Corp. is going to market with its energy portfolio, announcing Tuesday it was creating a new line of business called Lockheed MartinEnergy.
The Bethesda-based company is trying to get ahead of a shift in the global demand for energy. Frank Armijo, the newly appointed vice president of Lockheed MartinEnergy, said he anticipates that the need for new energy generation capacity will be driven by renewable sources — as much as 70 percent of new energy generation in the U.S. alone — in the years to come.
“We see energy as a global security and economic imperative,” Armijo said Tuesday at Lockheed’s 2016 Media Day.“It’s changing rapidly, the population is growing quite rapidly. ... The need for power is going to continue to grow."
For decades, the Lockheed energy businesses were captive and dispersed among its several divisions. The company began its foray into this particular line of business to meet customer cost savings and energy efficiency requirements on unrelated contract work. Through these ancillary jobs, executives said, Lockheed built up its energy chops and began attracting commercial and utilities clients.
Since January, Lockheed Martin Energy has booked $150 million in new work. The company said Tuesday it won a $43 million contract to build a bioenergy plant in Herten, Germany, which expects to take in 50,000 tons of raw waste a year and transform it into enough energy to power 5,000 homes and businesses.
Lockheed Martin Energy has five core areas: energy management, energy storage, nuclear systems, ocean technologies and bioenergy.
Energy management provides, as the name suggests, energy management and efficiency programs including smart grid technologies for utility customers. Theenergy storage line is focused on selling short- and long-duration energy storagetechnologies, a portfolio that was built up following Lockheed's August 2015 acquisition of Cambridge, Massachusetts-based Sun Catalytix Corp.
Bioenergy is related to the work in Herten, Germany, taking waste and converting it to energy. Ocean technologies will harness tides and temperature gradients to create energy. And nuclear systems — at 60 years old, one of the oldest of Lockheed’s energy businesses — is focused on Lockheed’s nuclear systems powering U.S. Navysubmarines and aircraft carriers and its digital systems monitoring nuclear plant safety.
In January, Lockheed divested $5 billion in government IT services and sold those assets to Reston-based Leidos Holdings Inc. , realigning its business units in the process. Prior to that strategic move, Lockheed's energy work was scattered throughout the corporation's several divisions.
Lockheed Martin Energy is a collection of the nuclear safety systems and energy storage businesses that once resided in its Missiles and Fire control unit, while its ocean technologies and bioenergy work came from Mission Systems and Training and the energy management systems and smart grid technology came from the recently divested Information Systems and Global Solutions portfolio.
These have all been consolidated into Lockheed Martin Energy, and will operate as a part of Missiles and Fire Control. The majority of Lockheed’s customers are commercial and utilities clients.
Source Washington Business Journal